Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TRVI - Trevi Therapeutics, Inc.
61.5 M
LAST VALUE
-25.68%
2 YEAR CAGR
284.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR